InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24
United States Fiscal year ends December CIK 0001326732
$24.63 +0.53% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $24.63 −34.20% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue109.0Operating income44.0Net income45.1EPS, diluted1.07Fiscal year 2017Revenue46.2 −57.7%Operating income−43.1Net income−38.5 −185.3%EPS, diluted−0.82 −176.6%Fiscal year 2018Revenue40.6 −12.0%Operating income−79.4Net income−70.4EPS, diluted−1.31Fiscal year 2019Revenue156.7 +285.9%Operating income13.8Net income26.9EPS, diluted0.46Fiscal year 2020Revenue122.7 −21.7%Operating income−76.8Net income−69.3 −358.0%EPS, diluted−1.21 −363.0%Fiscal year 2021Revenue275.1 +124.2%Operating income43.8Net income82.6EPS, diluted1.37Fiscal year 2022Revenue164.6 −40.2%Operating income−82.5Net income−55.2 −166.8%EPS, diluted−0.93 −167.9%Fiscal year 2023Revenue174.6 +6.1%Operating income−132.4Net income−133.1EPS, diluted−2.20Fiscal year 2024Revenue110.5 −36.7%Operating income−178.4Net income−232.6EPS, diluted−3.58Fiscal year 2025Revenue125.6 +13.7%Operating income−177.5Net income−91.9EPS, diluted−1.24
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 109.0 46.2 40.6 156.7 122.7 275.1 164.6 174.6 110.5 125.6
Growth −57.7% −12.0% +285.9% −21.7% +124.2% −40.2% +6.1% −36.7% +13.7%
Operating income 44.0 −43.1 −79.4 13.8 −76.8 43.8 −82.5 −132.4 −178.4 −177.5
Net income 45.1 −38.5 −70.4 26.9 −69.3 82.6 −55.2 −133.1 −232.6 −91.9
Growth −185.3% −358.0% −166.8%
EPS, diluted 1.07 −0.82 −1.31 0.46 −1.21 1.37 −0.93 −2.20 −3.58 −1.24
Growth −176.6% −363.0% −167.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin40.4%Net margin41.4%Free cash flow margin86.0%Fiscal year 2017Operating margin−93.4%Net margin−83.4%Free cash flow margin−84.3%Fiscal year 2018Operating margin−195.5%Net margin−173.4%Free cash flow margin−214.2%Fiscal year 2019Operating margin8.8%Net margin17.2%Free cash flow margin36.4%Fiscal year 2020Operating margin−62.6%Net margin−56.5%Free cash flow margin−12.7%Fiscal year 2021Operating margin15.9%Net margin30.0%Free cash flow margin−11.0%Fiscal year 2022Operating margin−50.1%Net margin−33.5%Free cash flow margin−8.5%Fiscal year 2023Operating margin−75.8%Net margin−76.2%Free cash flow margin−55.2%Fiscal year 2024Operating margin−161.5%Net margin−210.5%Free cash flow margin−188.5%Fiscal year 2025Operating margin−141.4%Net margin−73.2%Free cash flow margin−110.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 40.4% −93.4% −195.5% 8.8% −62.6% 15.9% −50.1% −75.8% −161.5% −141.4%
Net margin 41.4% −83.4% −173.4% 17.2% −56.5% 30.0% −33.5% −76.2% −210.5% −73.2%
Free cash flow margin 86.0% −84.3% −214.2% 36.4% −12.7% −11.0% −8.5% −55.2% −188.5% −110.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow95.2Capital expenditure−1.5Free cash flow93.7Fiscal year 2017Operating cash flow−33.6Capital expenditure−5.3Free cash flow−38.9 −141.5%Fiscal year 2018Operating cash flow−79.8Capital expenditure−7.2Free cash flow−87.0Fiscal year 2019Operating cash flow64.4Capital expenditure−7.4Free cash flow57.0Fiscal year 2020Operating cash flow−5.0Capital expenditure−10.5Free cash flow−15.5 −127.3%Fiscal year 2021Operating cash flow−16.9Capital expenditure−13.3Free cash flow−30.2Fiscal year 2022Operating cash flow24.5Capital expenditure−38.5Free cash flow−14.0Fiscal year 2023Operating cash flow−77.9Capital expenditure−18.4Free cash flow−96.4Fiscal year 2024Operating cash flow−202.2Capital expenditure−6.1Free cash flow−208.3Fiscal year 2025Operating cash flow−135.1Capital expenditure−3.2Free cash flow−138.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 95.2 −33.6 −79.8 64.4 −5.0 −16.9 24.5 −77.9 −202.2 −135.1
Capital expenditure −1.5 −5.3 −7.2 −7.4 −10.5 −13.3 −38.5 −18.4 −6.1 −3.2
Free cash flow 93.7 −38.9 −87.0 57.0 −15.5 −30.2 −14.0 −96.4 −208.3 −138.3
Growth −141.5% −127.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash14.5Shareholders’ equity337.9Fiscal year 2017Cash16.5Shareholders’ equity316.5Fiscal year 2018Cash26.2Shareholders’ equity521.7Fiscal year 2019Cash50.3Shareholders’ equity593.2Fiscal year 2020Cash163.5Shareholders’ equity572.4Fiscal year 2021Cash143.5Shareholders’ equity733.5Fiscal year 2022Cash53.9Total debt0.0Net cash (debt)53.9Shareholders’ equity727.5Debt to equity0.00Fiscal year 2023Cash53.8Total debt161.8Net cash (debt)−108.0Shareholders’ equity661.8Debt to equity0.24Fiscal year 2024Cash40.9Total debt115.2Net cash (debt)−74.3Shareholders’ equity677.6Debt to equity0.17Fiscal year 2025Cash54.1Total debt76.5Net cash (debt)−22.4Shareholders’ equity635.6Debt to equity0.12
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 14.5 16.5 26.2 50.3 163.5 143.5 53.9 53.8 40.9 54.1
Total debt n/a n/a n/a n/a n/a n/a 0.0 161.8 115.2 76.5
Net cash (debt) n/a n/a n/a n/a n/a n/a 53.9 −108.0 −74.3 −22.4
Shareholders’ equity 337.9 316.5 521.7 593.2 572.4 733.5 727.5 661.8 677.6 635.6
Debt to equity n/a n/a n/a n/a n/a n/a 0.00 0.24 0.17 0.12

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
109.0 46.2 40.6 156.7 122.7 275.1 164.6 174.6 110.5 125.6
Growth −57.7% −12.0% +285.9% −21.7% +124.2% −40.2% +6.1% −36.7% +13.7%
51.9 71.8 97.5 118.6 169.8 192.5 199.6 253.6 227.7 239.4
13.1 17.5 22.5 24.3 29.7 38.8 47.5 53.4 61.2 63.6
44.0 −43.1 −79.4 13.8 −76.8 43.8 −82.5 −132.4 −178.4 −177.5
Growth −197.9% −655.5% −288.4%
46.1 −38.9 −70.4 27.2 −69.3 82.6 −54.5 −119.6 −234.9 −89.6
1.0 −0.5 0.0 0.3 0.0 0.0 0.7 13.7 1.6 2.5
45.1 −38.5 −70.4 26.9 −69.3 82.6 −55.2 −133.1 −232.6 −91.9
Growth −185.3% −358.0% −166.8%
Per share
1.09 −0.82 −1.31 0.48 −1.21 1.42 −0.93 −2.20 −3.58 −1.24
1.07 −0.82 −1.31 0.46 −1.21 1.37 −0.93 −2.20 −3.58 −1.24
Growth −176.6% −363.0% −167.9%
41.3 46.8 53.9 56.5 57.2 58.4 59.7 60.5 65.0 74.2
42.4 46.8 53.9 58.5 57.2 60.5 59.7 60.5 65.0 74.2
Growth +10.4% +15.2% +8.4% −2.1% +5.7% −1.4% +1.4% +7.5% +14.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 0.5% a year over five years.
  • The diluted share count rose 29.8% in five years, which is dilution.
  • Operating margin is down 78.8 points on five years ago, at -141.4%.
  • A net loss in 7 of 10 years on file.